Drugs / S-588210
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02661659 | Jun 2016 → Oct 2017 | malignant pleural mesothelioma | University of Chicago | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S-588210 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02661659 ↗ |
| Modality | Vaccine | “Multipeptide vaccine S-588210” NCT02661659 ↗ |